Search

everythinglearnresearchcommunity

for

Search:↓

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

Frontal fibrosing alopecia can be diagnosed by examining facial areas and treated with specific medications to stop its progression.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Vertex accentuation is a common pattern in female hair loss.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

Isolated long hairs at the original hairline can help diagnose Frontal Fibrosing Alopecia.

Oxidative stress causes hair to gray by damaging and killing pigment cells.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Early treatment and multidisciplinary care are key to managing Frontal Fibrosing Alopecia and preventing further hair loss.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Postmenopausal women may experience frontal hairline and eyebrow loss due to cicatricial fibrosis.

Hair loss condition FFA was seen before the appearance of skin depigmentation vitiligo in a patient.

A 22-year-old's gray hair partially turned back to its original color without known causes.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Frontal fibrosing alopecia can mimic traction alopecia but has distinct features like facial papules and eyebrow thinning.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

FFA patients have fewer melanocytes and thinner skin compared to others.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.